Frequencies for first 10,000 rows of dose_vbm variable in drug2004q3 dataset : Verbatim text for dose, frequency, and | route, exactly as entered on report | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 7,178 71.78 71.78 ( IN 1 D), ORAL | 1 0.01 71.79 (100 MG), ORAL | 1 0.01 71.80 (2 GRAM,), INTRAVENOUS | 1 0.01 71.81 (2 MG) PER ORAL | 1 0.01 71.82 (30/500) 2 TAB QDS | 1 0.01 71.83 (300 ML) | 1 0.01 71.84 (40 MG), SUBCUTANEOUS | 1 0.01 71.85 (7.5 MG, 1-2 OD) , PO | 1 0.01 71.86 (UNIT DOSE) TABLETS | 1 0.01 71.87 ...MG/KG BID- SUBCUTANEOUS | 1 0.01 71.88 .125 MG, QD | 1 0.01 71.89 .25G TWICE PER DAY | 1 0.01 71.90 .25MG PER DAY | 2 0.02 71.92 .25UG PER DAY | 1 0.01 71.93 .2MG PER DAY | 2 0.02 71.95 .325MG PER DAY | 2 0.02 71.97 .3MCG PER DAY | 1 0.01 71.98 .5 MG/2 ML/ 1-2 WEEKS WITH MOST | 1 0.01 71.99 .5G PER DAY | 4 0.04 72.03 .5G THREE TIMES PER DAY | 2 0.02 72.05 .5MCG PER DAY | 3 0.03 72.08 .5MG AS REQUIRED | 1 0.01 72.09 .5MG PER DAY | 3 0.03 72.12 .5MG THREE TIMES PER DAY | 1 0.01 72.13 .5TAB PER DAY | 2 0.02 72.15 .5TAB TWICE PER DAY | 1 0.01 72.16 .5UD PER DAY | 1 0.01 72.17 .625MG UNKNOWN | 1 0.01 72.18 .6MG PER DAY | 1 0.01 72.19 .99MG PER DAY | 1 0.01 72.20 0.1 MG 2X/DAY | 1 0.01 72.21 0.1 ML ID X 1 [1 TIME ONLY] | 1 0.01 72.22 0.1 ML INTRADERMAL | 1 0.01 72.23 0.2 MG PO | 1 0.01 72.24 0.25 G TID PO | 1 0.01 72.25 0.25 MG | 1 0.01 72.26 0.25 MG PO QD | 1 0.01 72.27 0.3 MG (1 IN 1 D) | 1 0.01 72.28 0.4 MG.KG Q 12-24 HO INTRAVENOUS | 1 0.01 72.29 0.4Q6H X1 | 1 0.01 72.30 0.5 CC ADMINISTERED. | 1 0.01 72.31 0.5 DF DAILY; PO | 1 0.01 72.32 0.5 DF PO | 1 0.01 72.33 0.5 GM/KG IV Q 4 WKS [WITH US ~2/04 T.. | 1 0.01 72.34 0.5 MG PO BID | 1 0.01 72.35 0.5 MG/DAY | 2 0.02 72.37 0.5 MG/MIN DRIP | 1 0.01 72.38 0.6 MG BID | 1 0.01 72.39 0.6 MG/1 DAY | 1 0.01 72.40 0.75 MG,Q12HR, ORAL | 1 0.01 72.41 0.75 MGQ12HR, ORAL | 1 0.01 72.42 0.9 MG QD IM | 5 0.05 72.47 1 1 ORAL | 1 0.01 72.48 1 A DAY | 2 0.02 72.50 1 CAP + THEN 2 CAPS 2 HRS LATER. 2 MO.. | 1 0.01 72.51 1 CAPLET 3X PER DAY ORAL | 1 0.01 72.52 1 CAPSUL DAILY | 1 0.01 72.53 1 CARD, 1 IN 1 WK, PER ORAL | 1 0.01 72.54 1 CYCLE | 1 0.01 72.55 1 CYCLE 140 MG: 2 TID | 1 0.01 72.56 1 DAILY ORAL | 2 0.02 72.58 1 DF BID; PO | 1 0.01 72.59 1 DF DAILY | 1 0.01 72.60 1 DF OD, ORAL | 1 0.01 72.61 1 DF OF, ORAL | 1 0.01 72.62 1 DF ONCE PO | 1 0.01 72.63 1 DF ONCE; ED | 1 0.01 72.64 1 DF, ONCE/SINGLE | 2 0.02 72.66 1 DF, PRN | 2 0.02 72.68 1 DF, QD | 3 0.03 72.71 1 DF, QD, ORAL | 1 0.01 72.72 1 DF, QW3 | 1 0.01 72.73 1 DOSAGE FORMS | 1 0.01 72.74 1 DOSE(S), 3 IN 4 WEEK, TRANSDERMAL | 1 0.01 72.75 1 DOSE(S), 3 IN 4 WEEKS, TRANSDERMAL | 1 0.01 72.76 1 EVERY | 1 0.01 72.77 1 G | 1 0.01 72.78 1 G DAILY PO | 1 0.01 72.79 1 G TID PO | 1 0.01 72.80 1 G/D | 1 0.01 72.81 1 GM, 1 IN 1 D, INTRAVENOUS | 1 0.01 72.82 1 GM/M2 | 1 0.01 72.83 1 GRAM (1 D), INTRAVENOUS | 1 0.01 72.84 1 GRAM (BID), ORAL | 1 0.01 72.85 1 IN 1 D, ORAL | 2 0.02 72.87 1 IN 1 WEEK | 1 0.01 72.88 1 IN 2 MONTHS, INTRAVENOUS | 1 0.01 72.89 1 MG (1 MG, 1 IN 1 D), ORAL | 1 0.01 72.90 1 MG BID/ DURATION ABOUT 5 DAYS | 1 0.01 72.91 1 MG DAY | 1 0.01 72.92 1 MG ONCE INTRAMUSCULAR | 1 0.01 72.93 1 MG ONCE INTRAVENOUS | 1 0.01 72.94 1 MG QD PO | 1 0.01 72.95 1 MG, UNK | 1 0.01 72.96 1 MG/5 DAY | 1 0.01 72.97 1 MG/KG EVERY WEEK SQ | 1 0.01 72.98 1 MG/KG X 2 DOSES | 1 0.01 72.99 1 ORAL | 1 0.01 73.00 1 PATCH WEEKLY | 1 0.01 73.01 1 PER MOUTH DAILY | 1 0.01 73.02 1 PILL 2 X DAY ORAL | 1 0.01 73.03 1 PILL ORAL | 1 0.01 73.04 1 PO BID | 1 0.01 73.05 1 SPRAY QD | 1 0.01 73.06 1 SPRAY X 1, NASAL SPRAY | 1 0.01 73.07 1 SWAB 4 HOUR NASAL | 1 0.01 73.08 1 TAB LOR2/WEEK ORAL | 1 0.01 73.09 1 TAB ONCE A WEE ORAL | 1 0.01 73.10 1 TAB Q6H ORAL | 1 0.01 73.11 1 TAB QD | 1 0.01 73.12 1 TAB QHS ORAL | 1 0.01 73.13 1 TAB(S), 1X/DAY, ORAL | 1 0.01 73.14 1 TABLET (10 MG) TAKEN AT NIGHT | 1 0.01 73.15 1 TABLET 1 X PER 1 DAY, ORAL | 1 0.01 73.16 1 TABLET 1X PER 1 DAY ORAL | 1 0.01 73.17 1 TABLET 1X PER 1 DAY, ORAL | 1 0.01 73.18 1 TABLET AT NIGHT | 1 0.01 73.19 1 TABLET DAILY | 1 0.01 73.20 1 TABLET DAILY ORAL | 2 0.02 73.22 1 TABLET PER 1 DAY, ORAL | 1 0.01 73.23 1 TABLET, DAILY, ORAL | 1 0.01 73.24 1 TABLET, QD, ORAL | 1 0.01 73.25 1 TABLET/D | 1 0.01 73.26 1 TABLET/DAY | 2 0.02 73.28 1 TSP DAILY, ORAL | 1 0.01 73.29 1 UN QD PO | 1 0.01 73.30 1 UNK PO | 1 0.01 73.31 1,250.00 MG, BID | 1 0.01 73.32 1,5 DOSAGE FORMS | 1 0.01 73.33 1,950 MG IV | 1 0.01 73.34 1-2 G/D | 1 0.01 73.35 1.00 TABLET, QD, ORAL | 1 0.01 73.36 1.2 ML, SUBCUTANEOUS | 1 0.01 73.37 1.3 MG WEEKLY X FOUR DOSES | 1 0.01 73.38 1.34MG PER DAY | 1 0.01 73.39 1.4 MG/M2 EVERY 4 WEEKS | 1 0.01 73.40 1.5 EVERYDAY ORAL | 1 0.01 73.41 1.5 G QD PO | 1 0.01 73.42 1.5 GRAM ,ORAL | 1 0.01 73.43 1.5 MG, UNK | 1 0.01 73.44 1.5 MG/DAY , INTRAVENOUS | 1 0.01 73.45 1.5 MIU DAILY IV | 2 0.02 73.47 1.5 MIU DAILY; IV | 1 0.01 73.48 1.5-2.0 G/DAY X 15 DAYS/MO | 1 0.01 73.49 1.5G PER DAY | 1 0.01 73.50 1.5G THREE TIMES PER DAY | 1 0.01 73.51 1.5G UNKNOWN | 1 0.01 73.52 1.5MCG PER DAY | 1 0.01 73.53 1.5MG PER DAY | 1 0.01 73.54 1.5MGM2 PER DAY | 1 0.01 73.55 1.71 G QD INTRAVENOUS | 1 0.01 73.56 1.8 G/1 WEEK | 1 0.01 73.57 1.80 MCG (80MCG 1 IN 1 DAY(S)) | 1 0.01 73.58 1.89 MG, CYCLE 2, IV | 1 0.01 73.59 10 MG PO | 1 0.01 73.60 10 MG PO | 1 0.01 73.61 10 G QD TD | 1 0.01 73.62 10 MG | 5 0.05 73.67 10 MG PO | 2 0.02 73.69 10 MG ( 1 IN 1 D ) ORAL | 1 0.01 73.70 10 MG ( 10 MG, 1 IN 1 D), ORAL | 1 0.01 73.71 10 MG (10 MG, 1 IN 1 D) | 1 0.01 73.72 10 MG (10 MG, 1 IN 1 D) ORAL | 2 0.02 73.74 10 MG (10 MG, 1 IN 1 D), ORAL | 3 0.03 73.77 10 MG (D1 - D8 Q 21DAYS), INTRAVENOUS | 1 0.01 73.78 10 MG /ONCE PER DAY/EVENINGS | 1 0.01 73.79 10 MG 1/2 TAB QD PO | 1 0.01 73.80 10 MG 2 TIMES ORAL | 1 0.01 73.81 10 MG BID PO | 1 0.01 73.82 10 MG DAILY | 4 0.04 73.86 10 MG DAILY ORAL | 1 0.01 73.87 10 MG DAILY PO | 55 0.55 74.42 10 MG DAILY; PO | 3 0.03 74.45 10 MG DAY ORAL | 1 0.01 74.46 10 MG EVERY DAY ORAL | 1 0.01 74.47 10 MG FROM 21-MAR TO 27-MAY 20 MG FRO.. | 1 0.01 74.48 10 MG HS PO | 3 0.03 74.51 10 MG HS PO; 5 MG PO | 1 0.01 74.52 10 MG IV | 4 0.04 74.56 10 MG ONCE PO | 1 0.01 74.57 10 MG P0 | 1 0.01 74.58 10 MG PO | 240 2.40 76.98 10 MG PO DAILY | 1 0.01 76.99 10 MG PO QAM | 1 0.01 77.00 10 MG PO QD | 1 0.01 77.01 10 MG Q DAY ORAL | 1 0.01 77.02 10 MG Q0D PO | 1 0.01 77.03 10 MG QAM PO | 1 0.01 77.04 10 MG QD | 3 0.03 77.07 10 MG QD PO | 166 1.66 78.73 10 MG QD; PO | 14 0.14 78.87 10 MG QOD | 1 0.01 78.88 10 MG QOD PO | 7 0.07 78.95 10 MG QOD; PO | 1 0.01 78.96 10 MG TIWK PO | 1 0.01 78.97 10 MG, 1 IN 1 D, ORAL | 3 0.03 79.00 10 MG, 1 IN 1 D, PER ORAL | 2 0.02 79.02 10 MG, 1 IN 1 DAY, ORAL | 1 0.01 79.03 10 MG, BID ; 20 MG ; 40 MG | 1 0.01 79.04 10 MG, DAILY | 2 0.02 79.06 10 MG, DAILY, ORAL | 1 0.01 79.07 10 MG, IN 1 DAY, ORAL | 1 0.01 79.08 10 MG, QD | 4 0.04 79.12 10 MG, QD, ORAL | 1 0.01 79.13 10 MG, QHS | 1 0.01 79.14 10 MG, QMO | 1 0.01 79.15 10 MG, SEE TEXT | 1 0.01 79.16 10 MG, TID | 1 0.01 79.17 10 MG, TOTAL DAILY, ORAL | 1 0.01 79.18 10 MG, UNK | 2 0.02 79.20 10 MG/1 DAY | 1 0.01 79.21 10 MG/D | 2 0.02 79.23 10 MG/DAY | 5 0.05 79.28 10 MG/DAY , ORAL | 1 0.01 79.29 10 MG/KG/D | 1 0.01 79.30 10 MG; PO | 4 0.04 79.34 10 MIU INTRAMUSCULAR | 1 0.01 79.35 10 U DAY | 1 0.01 79.36 10-20MG QD PO | 1 0.01 79.37 10.7 MG/KG/D | 1 0.01 79.38 10.8 MG Q 3 MONTHS X 1 | 1 0.01 79.39 10.8 MG Q3MO SQ | 2 0.02 79.41 10/12.5 MG | 1 0.01 79.42 10/20 ORAL DAILY | 1 0.01 79.43 10/20 QD | 1 0.01 79.44 100 MCG EVERY 3 DA TRANSDERMAL | 1 0.01 79.45 100 MG | 2 0.02 79.47 100 MG (AS NEEDED), ORAL | 1 0.01 79.48 100 MG 1 DAY ORAL | 1 0.01 79.49 100 MG AT BEDTIME ORAL | 2 0.02 79.51 100 MG DAILY ORAL | 1 0.01 79.52 100 MG DAILY; PO | 2 0.02 79.54 100 MG ONCE IV | 1 0.01 79.55 100 MG PO QD [CHRONIC LONG TERM] | 1 0.01 79.56 100 MG Q 3 HOURS X 4-5 DAYS | 1 0.01 79.57 100 MG QD PO | 1 0.01 79.58 100 MG TID ORAL | 1 0.01 79.59 100 MG TID PO | 1 0.01 79.60 100 MG, 1X/DAY, ORAL | 1 0.01 79.61 100 MG, BID | 1 0.01 79.62 100 MG, BIW | 1 0.01 79.63 100 MG, DAILY, ORAL | 2 0.02 79.65 100 MG, DAILY, X 2 DAYS, ORAL | 1 0.01 79.66 100 MG, ORAL | 1 0.01 79.67 100 MG, QD | 1 0.01 79.68 100 MG, QD, ORAL | 3 0.03 79.71 100 MG, TID | 1 0.01 79.72 100 MG, TOTAL DAILY, ORAL | 2 0.02 79.74 100 MG, UNK | 2 0.02 79.76 100 MG/D | 4 0.04 79.80 100 MG/DAY | 3 0.03 79.83 100 MG/M2 OTHER - INTRAVENOUS NOS | 1 0.01 79.84 100 MI, UNK, INTRAVENOUS | 1 0.01 79.85 100 ML (2 ML/SEC), INTRAVENOUS | 1 0.01 79.86 100 TABLETS, ONCE/SINGLE | 1 0.01 79.87 100 U DAY | 1 0.01 79.88 100 UG. 1 IN 72 HOUR, TRANSDERMAL | 1 0.01 79.89 100 UG/HR, 1 IN 48 HOUR, TRANSDERMAL | 2 0.02 79.91 100 UG/HR, 1 IN 72 HOUR, TRANSDERMAL | 1 0.01 79.92 100-50 MG/DAY | 1 0.01 79.93 1000 MG | 1 0.01 79.94 1000 MG (100 MG, 100 MG) PO | 1 0.01 79.95 1000 MG (200 MG, 5 IN 1 D) | 1 0.01 79.96 1000 MG DAILY PO | 1 0.01 79.97 1000 MG IV Q 24 HRS | 1 0.01 79.98 1000 MG Q 12 HOURS IVPB | 1 0.01 79.99 1000 MG QD ORAL | 1 0.01 80.00 1000 MG QD PO | 1 0.01 80.01 1000 MG QHS ORAL | 1 0.01 80.02 1000 MG, ORAL | 1 0.01 80.03 1000 MG/D | 1 0.01 80.04 1000 MG/DAY | 1 0.01 80.05 1000 MG/M2 OTHER | 1 0.01 80.06 1000 MG/M2 Q3W, INTRAVENOUS NOS | 1 0.01 80.07 1000MG PER DAY | 5 0.05 80.12 1000MG THREE TIMES PER DAY | 8 0.08 80.20 1000MG TWICE PER DAY | 1 0.01 80.21 1000MG/M2 DAY 1 + 15 INTRAVENOUS | 1 0.01 80.22 1000ML PER DAY | 1 0.01 80.23 100MCG PER DAY | 2 0.02 80.25 100MG AS REQUIRED | 1 0.01 80.26 100MG ESCALATED TO 400MG, DAILY, ORAL | 1 0.01 80.27 100MG FOUR TIMES PER DAY | 1 0.01 80.28 100MG PER DAY | 18 0.18 80.46 100MG PRN X 1 ORAL | 1 0.01 80.47 100MG THREE TIMES PER DAY | 2 0.02 80.49 100MG TWICE PER DAY | 1 0.01 80.50 100MG/D | 1 0.01 80.51 100MG/DAY | 2 0.02 80.53 100UG PER DAY | 1 0.01 80.54 104000 UNITS ONE DOSE IM | 1 0.01 80.55 10G PER DAY | 1 0.01 80.56 10MG DAILY ORAL | 1 0.01 80.57 10MG PER DAY | 17 0.17 80.74 10MG QD ORAL | 1 0.01 80.75 10MG QOD ORAL; 10 MG ORAL | 1 0.01 80.76 10MG THREE TIMES PER DAY | 2 0.02 80.78 10MG TWICE PER DAY | 5 0.05 80.83 10ML PER DAY | 1 0.01 80.84 10UNIT AT NIGHT | 1 0.01 80.85 1110 MG Q3W IV | 2 0.02 80.87 112 UG, QD | 1 0.01 80.88 114 IU, IU, QD, INTRAUTERINE | 1 0.01 80.89 114 IU,QD, QD, INTRAUTERINE | 1 0.01 80.90 12 MG (SINGLE DOSE), IT ; IV | 1 0.01 80.91 12 MG ON 4/12/04, DAY 38 | 1 0.01 80.92 12 MG ONE DOSE INTRATHECAL | 1 0.01 80.93 12 MG/DAY | 1 0.01 80.94 12 MG/KG/D | 1 0.01 80.95 12 U DAY | 2 0.02 80.97 12.5 MG, QOD | 1 0.01 80.98 12.5 MG/DAY | 1 0.01 80.99 12.5MG ORAL | 1 0.01 81.00 12.5MG TWICE PER DAY | 2 0.02 81.02 120 MG, UNK | 1 0.01 81.03 120 MG/DAY | 2 0.02 81.05 120 MG/M2 GIVEN ON DAYS 1, 2 AND 3, I.. | 1 0.01 81.06 120 TID | 1 0.01 81.07 120 UG, 1 IN 1 DAY, SUBCUTANEOUS | 1 0.01 81.08 1200 MG (300 MG, 4 IN 1 D) | 1 0.01 81.09 1200 MG (600 MG, 2 IN 1 D) | 1 0.01 81.10 1200 MG (600 MG, 2 IN 1 D), ORAL | 1 0.01 81.11 1200 MG (600 MG, 2 IN 1D), ORAL | 1 0.01 81.12 1200 MG 3X/WK OVER 8 HRS SQ | 1 0.01 81.13 1200 MG PO QD [CHRONIC LONG-TERM] | 1 0.01 81.14 1200 MG QD ORAL | 2 0.02 81.16 1200 MG TWICE A DA | 1 0.01 81.17 1200 MG/DAY | 2 0.02 81.19 1200 QAM + 600 QPM | 1 0.01 81.20 1200MG PER DAY | 1 0.01 81.21 120MG PER DAY | 1 0.01 81.22 1240 MG SQ DAILY | 1 0.01 81.23 125 MCG | 1 0.01 81.24 125 MG DAILY; PO | 1 0.01 81.25 125 MG QD | 1 0.01 81.26 125 MG, QD | 2 0.02 81.28 125 MG/D | 2 0.02 81.30 125 MG/DAY | 2 0.02 81.32 125 UG/HR, 1 IN 72 HOUR, TRANSDERMAL | 1 0.01 81.33 125 UG/HR, TRANSDERMAL; SEE IMAGE | 1 0.01 81.34 1250 MG, BID | 1 0.01 81.35 1250MG TWICE PER DAY | 1 0.01 81.36 125MG PER DAY | 3 0.03 81.39 125MG/DAY | 1 0.01 81.40 130 MG/M2 Q2W, INTRAVENOUS NOS | 1 0.01 81.41 132 ML, SINGLE DOSE, I.A. | 1 0.01 81.42 134 MG IV Q 2 WKS | 1 0.01 81.43 1400MG PER DAY | 1 0.01 81.44 144 MG IV Q 2 WKS | 1 0.01 81.45 145 MG DAY 1 INTRAVENOUS | 1 0.01 81.46 145MG DAY 1 INTRAVENOUS | 1 0.01 81.47 15 DROPS/DAY | 1 0.01 81.48 15 G, INTRAVENOUS | 1 0.01 81.49 15 MG | 2 0.02 81.51 15 MG (1 D); PER ORAL | 1 0.01 81.52 15 MG (1D), PER ORAL | 1 0.01 81.53 15 MG DAILY | 1 0.01 81.54 15 MG QD PO | 1 0.01 81.55 15 MG QW IM | 1 0.01 81.56 15 MG, 1 IN 1 WK, PER ORAL | 1 0.01 81.57 15 MG, HS | 1 0.01 81.58 15 MG, PO | 1 0.01 81.59 15 MG, QD, TRANDSDERMAL | 1 0.01 81.60 15 MG/D | 1 0.01 81.61 15 MG/DAY | 1 0.01 81.62 15 MG/KG/D | 1 0.01 81.63 15 NOV 2002 TO 15 JAN 2003 (EST), AM.. | 1 0.01 81.64 15 U DAY | 1 0.01 81.65 15 U/2 DAY | 1 0.01 81.66 150 MCG QW SUBCUTANEOUS | 2 0.02 81.68 150 MCG SUBCUTANEOUS | 1 0.01 81.69 150 MG | 1 0.01 81.70 150 MG PO | 1 0.01 81.71 150 MG (150 MG, 150MG/D) | 1 0.01 81.72 150 MG (50 MG, 3 IN 1D), ORAL | 1 0.01 81.73 150 MG 1X PER 1 DAY ORAL | 1 0.01 81.74 150 MG 1X PER 1 DAY ORAL; 75 MG 1X PE.. | 1 0.01 81.75 150 MG DAILY ORAL | 1 0.01 81.76 150 MG DAILY PO | 1 0.01 81.77 150 MG Q2W, INTRAVENOUS NOS | 1 0.01 81.78 150 MG Q2W, INTRAVENOUS NOS | 1 0.01 81.79 150 MG SOLUTION, INTRAVENOUS; SEE IMAGE | 1 0.01 81.80 150 MG, 1X/DAY, ORAL | 1 0.01 81.81 150 MG, QD | 1 0.01 81.82 150 MG/DAY | 4 0.04 81.86 1500 MG | 1 0.01 81.87 1500 MG (1000 MG/M2 TWICE DAILY FOR 2.. | 1 0.01 81.88 1500 MG (1000 MG/M2 TWICE DAILY FOR 2.. | 1 0.01 81.89 1500MG PER DAY | 1 0.01 81.90 150MG PER DAY | 12 0.12 82.02 150MG SEE DOSAGE TEXT | 2 0.02 82.04 150MG TWICE PER DAY | 3 0.03 82.07 150MG UNKNOWN | 2 0.02 82.09 150MG/DAY | 1 0.01 82.10 1518 MG (DAY 1 Q 21 DAUS), INTRAVENOUS | 1 0.01 82.11 15MG FOUR TIMES PER DAY | 1 0.01 82.12 15MG PER DAY | 6 0.06 82.18 15MG TWICE PER DAY | 2 0.02 82.20 16 MG (16 MG, 1 IN 1 D) , ORAL | 1 0.01 82.21 160 M / TWO DIVIDED DOSES | 1 0.01 82.22 160 MG (80 MG, 2 IN 1 D) | 1 0.01 82.23 160 MG PO | 1 0.01 82.24 160 MG QD PO | 2 0.02 82.26 160 MG, 2X/DAY, ORAL | 1 0.01 82.27 160 MG, QD | 3 0.03 82.30 160 MG/DAY | 4 0.04 82.34 1600 MG IV WEEKLY X2 THEN /.WK OFF | 1 0.01 82.35 160MG PER DAY | 5 0.05 82.40 17 MG/KG/D | 1 0.01 82.41 170 MG D 1 IV | 1 0.01 82.42 172 MG IV Q 2 WKS | 1 0.01 82.43 173 MG Q MONTH IV | 1 0.01 82.44 175 MG IV Q WK | 1 0.01 82.45 175 MG/D | 1 0.01 82.46 18 MCG | 1 0.01 82.47 18 MCG (18 MCG, 18 MCG ONCE DAILY), IH | 1 0.01 82.48 18 MCG 918 MCG, 1 PUFF DAILY) IH | 1 0.01 82.49 18 MCG, IH | 1 0.01 82.50 18 MG (5X/WK, 2WKS ON, 2WKS OFF), IVI | 1 0.01 82.51 18 MG, IN 1 DAY, ORAL | 1 0.01 82.52 18 MG/KG/D | 1 0.01 82.53 180 MG / DAY | 2 0.02 82.55 180 MG DAILY | 1 0.01 82.56 1800 MG (600 MG, 3 IN 1 D), ORAL | 1 0.01 82.57 1800 MG/1 OTHER | 1 0.01 82.58 187 MG Q3W, INTRAVENOUS NOS | 1 0.01 82.59 187 MG Q3W; INTRAVENOUS NOS | 1 0.01 82.60 18MG ORAL | 1 0.01 82.61 190 MG/DAY | 1 0.01 82.62 1950 MG DAY 1 + 8 IV | 1 0.01 82.63 196 MG IV Q 2 WKS | 1 0.01 82.64 1CAP PER DAY | 4 0.04 82.68 1CAP TWICE PER DAY | 1 0.01 82.69 1G FOUR TIMES PER DAY | 1 0.01 82.70 1G PER DAY | 9 0.09 82.79 1G TWICE PER DAY | 4 0.04 82.83 1G X 4 = 4000MG/DAY | 1 0.01 82.84 1MCG PER DAY | 2 0.02 82.86 1MG CYCLIC | 3 0.03 82.89 1MG FOUR TIMES PER DAY | 1 0.01 82.90 1MG PER DAY | 4 0.04 82.94 1MGM2 PER DAY | 1 0.01 82.95 1O MG PO | 2 0.02 82.97 1PUFF PER DAY | 1 0.01 82.98 1PUFF TWICE PER DAY | 1 0.01 82.99 1ST DOSE | 1 0.01 83.00 1ST DOSE = 90 MG 2ND = 80 MG 3RD = 70.. | 1 0.01 83.01 1ST INFUSION, 100 CC ADMINISTERED | 1 0.01 83.02 1TAB PER DAY | 9 0.09 83.11 1TAB TWICE PER DAY | 3 0.03 83.14 1U PER DAY | 2 0.02 83.16 1U TWICE PER DAY | 1 0.01 83.17 1UD PER DAY | 1 0.01 83.18 1UNIT FOUR TIMES PER DAY | 1 0.01 83.19 1UNIT PER DAY | 4 0.04 83.23 1UNIT THREE TIMES PER DAY | 1 0.01 83.24 1UNIT TWICE PER DAY | 2 0.02 83.26 1X/DAY | 1 0.01 83.27 2 (7.9 ML BOLUSES) 14 ML/HR IV | 1 0.01 83.28 2 1/2 | 1 0.01 83.29 2 CAPS/DAY | 1 0.01 83.30 2 DAILY (2 DAILY), IU | 1 0.01 83.31 2 DF DAILY | 1 0.01 83.32 2 DF, ONCE/SINGLE | 1 0.01 83.33 2 DF, UNK | 2 0.02 83.35 2 DOSES ORAL | 1 0.01 83.36 2 G /VIAL FOR INJECTION | 1 0.01 83.37 2 GRAM (1 GRAM, 2 IN 1 D), INTRAVENOUS | 1 0.01 83.38 2 MG DAILY (2 WEEKS ON /2 WEEKS OFF) | 1 0.01 83.39 2 MG QD ORAL | 1 0.01 83.40 2 MG, B ID | 1 0.01 83.41 2 MG, QD, ORAL | 1 0.01 83.42 2 MG/DAY | 1 0.01 83.43 2 MG/ML ONCE IV | 1 0.01 83.44 2 MIU, EVERY 2D, SUBCUTANEOUS | 2 0.02 83.46 2 TAB QAM | 1 0.01 83.47 2 TO 5 TIMES PER DAY; TRANSPLACENTAL | 1 0.01 83.48 2 X 500MG | 1 0.01 83.49 2( 95ML BOLUSES) 17ML/HR IV | 1 0.01 83.50 2(6.2 ML BOLUSES)5.5 ML/HR IV | 1 0.01 83.51 2-5 TIMES DAILY | 1 0.01 83.52 2.00 TABLET, SINGLE, ORAL | 1 0.01 83.53 2.2G TWICE PER DAY | 1 0.01 83.54 2.4 MG, QD, SUBCUTANEOUS | 1 0.01 83.55 2.5 MG BID ON SATURDAY PO | 1 0.01 83.56 2.5 MG PO | 3 0.03 83.59 2.5 MG QD PO | 1 0.01 83.60 2.5 MG QD; SUBCUTANTOUS | 1 0.01 83.61 2.5 MG, QD | 1 0.01 83.62 2.5 MG, QHS | 1 0.01 83.63 2.5 MG, UNK | 2 0.02 83.65 2.5 MG/ 5 MG | 1 0.01 83.66 2.5 MG/2 DAY | 1 0.01 83.67 2.5 MG/D | 1 0.01 83.68 2.5 UG/DAY | 1 0.01 83.69 2.5G PER DAY | 1 0.01 83.70 2.5MG PER DAY | 1 0.01 83.71 20 MG | 4 0.04 83.75 20 MG (1 IN 1 D), ORAL | 1 0.01 83.76 20 MG (20 MG) PO | 1 0.01 83.77 20 MG (20 MG, 1 IN 1D) | 1 0.01 83.78 20 MG / DAY | 1 0.01 83.79 20 MG 1X PER 1 WK, ORAL | 2 0.02 83.81 20 MG BID PO | 2 0.02 83.83 20 MG DAILY | 1 0.01 83.84 20 MG DAILY PO | 9 0.09 83.93 20 MG DAILY; PO | 1 0.01 83.94 20 MG DAY | 1 0.01 83.95 20 MG HS PO | 1 0.01 83.96 20 MG IV | 1 0.01 83.97 20 MG ONCE IN 28 DAYS | 1 0.01 83.98 20 MG PO | 8 0.08 84.06 20 MG PO HS | 1 0.01 84.07 20 MG PO QD | 1 0.01 84.08 20 MG PO QPM | 1 0.01 84.09 20 MG PRN PO | 2 0.02 84.11 20 MG QAM ORAL | 1 0.01 84.12 20 MG QD ORAL | 1 0.01 84.13 20 MG QD PO | 7 0.07 84.20 20 MG QD; PO | 1 0.01 84.21 20 MG QDAY ORAL | 1 0.01 84.22 20 MG QHS ORAL | 1 0.01 84.23 20 MG ^PO^ Q DAY | 1 0.01 84.24 20 MG, 1 IN 12 HR, PER ORAL | 1 0.01 84.25 20 MG, QD | 3 0.03 84.28 20 MG, TID | 1 0.01 84.29 20 MG, TOTAL DAILY, ORAL | 1 0.01 84.30 20 MG, UNK | 2 0.02 84.32 20 MG/1 | 1 0.01 84.33 20 MG/D | 6 0.06 84.39 20 MG/DAY | 8 0.08 84.47 20 MG/M2 DAY 1 +15 | 1 0.01 84.48 20 ML/D | 1 0.01 84.49 20 U DAY | 2 0.02 84.51 20 U/L DAY | 1 0.01 84.52 20 UG DAY | 6 0.06 84.58 20 UG/1 DAY | 13 0.13 84.71 20 UG/DAY | 3 0.03 84.74 20 UG/DAY, CONT, INTRA-UTERINE | 3 0.03 84.77 20.00 MG, UID/QD | 1 0.01 84.78 200 CGY 5 TIMES OTHER | 1 0.01 84.79 200 IU, QD | 2 0.02 84.81 200 MG (200 MG, 200MG/D)PO | 1 0.01 84.82 200 MG 1X PER 1 DAY | 1 0.01 84.83 200 MG BID ORAL | 1 0.01 84.84 200 MG DAILY | 1 0.01 84.85 200 MG DAILY PO | 1 0.01 84.86 200 MG DAY ORAL | 1 0.01 84.87 200 MG OTEHR (CUMULATIVE DOSE: 200 MG.. | 1 0.01 84.88 200 MG OTHER (CUMULATIVE DOSE : 200 M.. | 1 0.01 84.89 200 MG PO BID | 1 0.01 84.90 200 MG PO QD | 1 0.01 84.91 200 MG Q 4 HOURS 5X A DAY X 4 DAYS | 1 0.01 84.92 200 MG QD | 1 0.01 84.93 200 MG TO 400MG DAILY, ORAL | 1 0.01 84.94 200 MG, BID, ORAL | 2 0.02 84.96 200 MG, HS, ORAL | 1 0.01 84.97 200 MG, ORAL | 1 0.01 84.98 200 MG, QD | 2 0.02 85.00 200 MG, QD, INTRAVENOUS ; 200 MG, BID.. | 1 0.01 85.01 200 MG, QD, ORAL | 1 0.01 85.02 200 MG, TABLET ORAL | 1 0.01 85.03 200 MG, TID | 4 0.04 85.07 200 MG/D | 3 0.03 85.10 200 MG/DAY | 5 0.05 85.15 200 MG; ORAL | 1 0.01 85.16 200 UG/HR, 1 IN 48 HOUR, TRANSDERMAL | 1 0.01 85.17 200-250 MG | 1 0.01 85.18 2000 MG PER_ CYCLE IV | 1 0.01 85.19 2000 MG PO BID | 1 0.01 85.20 2000 MG, 1 IN 1 D, PER ORAL | 1 0.01 85.21 200MG FOUR TIMES PER DAY | 1 0.01 85.22 200MG PER DAY | 8 0.08 85.30 200MG SEE DOSAGE TEXT | 1 0.01 85.31 200MG THREE TIMES PER DAY | 2 0.02 85.33 200MG TO 400MG DAILY, ORAL | 1 0.01 85.34 200MG TWICE PER DAY | 2 0.02 85.36 200MGML PER DAY | 1 0.01 85.37 208 MG, QWK X 4 WEEKS THEN 2 WEEKS OF.. | 1 0.01 85.38 20MG PER DAY | 23 0.23 85.61 20MG UNKNOWN | 2 0.02 85.63 20ML PER DAY | 1 0.01 85.64 210 MG D1-3 IV | 1 0.01 85.65 2124 MG, INTRAVENOUS | 1 0.01 85.66 22 MCG, NOT REPORTED, | 1 0.01 85.67 22 UNITS AM, 20 UNITS PM | 1 0.01 85.68 220 MG, QD, ORAL | 1 0.01 85.69 2200 U X FOUR DOSES | 1 0.01 85.70 225-475 MG QD ORAL | 1 0.01 85.71 2250 MG | 2 0.02 85.73 225MG PER DAY | 1 0.01 85.74 22UNIT PER DAY | 1 0.01 85.75 23.75 DAILY PO | 1 0.01 85.76 24 IU, QD, SUBCUTANEOUS; 20 IU, QD, S.. | 1 0.01 85.77 24 MG/KG, DIVIDED INTO THREE | 1 0.01 85.78 24 MG/KG, DIVIDED INTO THREE DOSES., .. | 3 0.03 85.81 24 MG/KG/HR | 1 0.01 85.82 24 U DAY | 1 0.01 85.83 24 UG/KG/HR | 4 0.04 85.87 240 MG / THREE DIVIDED DOSES | 1 0.01 85.88 240 MG OD, ORAL | 1 0.01 85.89 240 MG OD, ORAL | 1 0.01 85.90 240MG AT NIGHT | 1 0.01 85.91 245 MG, TOTAL DAILY | 1 0.01 85.92 2460 MG QD CONTINUOUS SQ | 1 0.01 85.93 24MG PER DAY | 2 0.02 85.95 25 MG | 1 0.01 85.96 25 MG ONCE INTRAMUSCULAR | 1 0.01 85.97 25 MG ONE TIME INTRAMUSCULAR | 1 0.01 85.98 25 MG PRN AT ONS ORAL | 1 0.01 85.99 25 MG QD | 1 0.01 86.00 25 MG, 1 IN 1 DAY, ORAL | 1 0.01 86.01 25 MG, BID | 1 0.01 86.02 25 MG, QD | 1 0.01 86.03 25 MG, UNK | 1 0.01 86.04 25 MG/D | 3 0.03 86.07 25 MG/DAY | 1 0.01 86.08 25 MG/KG, DIVIDED INTO THREE DOSES, D.. | 1 0.01 86.09 25 MG/KG/D | 1 0.01 86.10 25 MG/KG/HR | 1 0.01 86.11 25 MG/M2 Q2W, INTRAVENOUS NOS | 2 0.02 86.13 25 MG/M2, 5 CYCLES X 5D, INTRAVENOUS | 1 0.01 86.14 25 UG/HR, 1 IN 72 HOUR, TRANSDERMAL | 2 0.02 86.16 25-50 MG | 1 0.01 86.17 250 MCG (125 MCG, 2 IN 1 D), ORAL | 1 0.01 86.18 250 MG | 1 0.01 86.19 250 MG (125 MCG, 2 IN 1D), ORAL | 1 0.01 86.20 250 MG (250 MG, 1 IN 1 D), ORAL | 1 0.01 86.21 250 MG (250 MG, DAILY) ORAL | 1 0.01 86.22 250 MG BY MOUTH X 6 MONTHS | 1 0.01 86.23 250 MG DAILY PO | 6 0.06 86.29 250 MG IV QD | 1 0.01 86.30 250 MG MONTH IM | 1 0.01 86.31 250 MG TWICE A DA ORAL | 1 0.01 86.32 250 MG, QD | 5 0.05 86.37 250 MG/DAY | 3 0.03 86.40 2500 MG, IU | 1 0.01 86.41 2500MG PER DAY | 1 0.01 86.42 250MCG TWICE PER DAY | 1 0.01 86.43 250MG PER DAY | 4 0.04 86.47 250MG TWICE PER DAY | 1 0.01 86.48 25MG AS REQUIRED | 2 0.02 86.50 25MG PER DAY | 5 0.05 86.55 25MG SEVEN TIMES PER DAY | 1 0.01 86.56 25MG TWICE PER DAY | 2 0.02 86.58 26 U DAY | 1 0.01 86.59 260 MG/M2 | 1 0.01 86.60 2600 MG / M2 Q 3 WK | 1 0.01 86.61 265 MG IV Q 21 DAYS | 1 0.01 86.62 27 MCG/ML | 1 0.01 86.63 2700 MG (900 MG, 3 IN 1 D), ORAL | 1 0.01 86.64 28 U DAY | 1 0.01 86.65 28 U/3 DAY | 1 0.01 86.66 2G PER DAY | 2 0.02 86.68 2G THREE TIMES PER DAY | 3 0.03 86.71 2MG PER DAY | 7 0.07 86.78 2MG TABLET X 2.5/DAY= 5MG DAY | 1 0.01 86.79 2MG THREE TIMES PER DAY | 1 0.01 86.80 2ND CYCLE ADMINISTERED ON 18-MAY-2004 | 2 0.02 86.82 2PUFF AT NIGHT | 1 0.01 86.83 2PUFF TWICE PER DAY | 3 0.03 86.86 2TAB FOUR TIMES PER DAY | 1 0.01 86.87 2TAB PER DAY | 7 0.07 86.94 2UD PER DAY | 1 0.01 86.95 2UNIT PER DAY | 6 0.06 87.01 3 CAPSUL BID ORAL | 1 0.01 87.02 3 DF QD , ORAL | 1 0.01 87.03 3 DF QD ORAL | 1 0.01 87.04 3 G DAILY PO, 3 G DAILY PO | 1 0.01 87.05 3 G/M2 | 1 0.01 87.06 3 MG, 1 IN 1 D, ORAL | 1 0.01 87.07 3 MG, IN 1 DAY, ORAL | 1 0.01 87.08 3 MG/KG, 1 IN 1 AS NECESSARY, INTRAVE.. | 1 0.01 87.09 3 PO QAM 3 PO Q PM 2 PO Q HS | 1 0.01 87.10 3 TABLESP./DAY | 1 0.01 87.11 3 TO 5 MG | 1 0.01 87.12 3.00 MG, BID | 1 0.01 87.13 3.125MG TWICE PER DAY | 1 0.01 87.14 3.410 UNITS IV | 1 0.01 87.15 3.5 MG/KG/DAY, ORAL | 1 0.01 87.16 3.6 MG SC | 1 0.01 87.17 3.75MG= 2.75MG/5MG ALTERNATE DAYS; DU.. | 1 0.01 87.18 30 MCG QW IM | 54 0.54 87.72 30 MG | 1 0.01 87.73 30 MG (30 MG, 1 IN 1 D), PER ORAL | 1 0.01 87.74 30 MG DAY ORAL | 1 0.01 87.75 30 MG ONCE IN 28 DAYS | 1 0.01 87.76 30 MG PO QD | 1 0.01 87.77 30 MG QD PO | 1 0.01 87.78 30 MG, 2 IN 1 DAY, ORAL | 1 0.01 87.79 30 MG, UNK | 1 0.01 87.80 30 MG/D | 3 0.03 87.83 30 MG/DAY | 4 0.04 87.87 30 MG/M2 | 1 0.01 87.88 30 U DAY | 3 0.03 87.91 30-15 MG PER ORAL | 1 0.01 87.92 300 MG (300 , 300MG/D) | 1 0.01 87.93 300 MG , ORAL | 1 0.01 87.94 300 MG / THREE TIMES PER DAY/ ORAL | 1 0.01 87.95 300 MG 1X PER 1 DAY ORAL | 1 0.01 87.96 300 MG 1X PER 1 DAY ORAL; UNSPECIFIED.. | 1 0.01 87.97 300 MG 2X A WEEK PO | 1 0.01 87.98 300 MG DAILY PO | 1 0.01 87.99 300 MG PO BID | 1 0.01 88.00 300 MG PO QD | 2 0.02 88.02 300 MG Q 24 H | 1 0.01 88.03 300 MG Q8H ORAL | 1 0.01 88.04 300 MG QDAY PO | 1 0.01 88.05 300 MG, 1 IN 1 D, ORAL | 1 0.01 88.06 300 MG, 1 IN 1 D, PER ORAL | 1 0.01 88.07 300 MG, 2 IN 1 D, PER ORAL | 1 0.01 88.08 300 MG, BID | 3 0.03 88.11 300 MG, DAILY, ORAL | 1 0.01 88.12 300 MG, INTRAVENOUS | 1 0.01 88.13 300 MG, ORAL | 1 0.01 88.14 300 MG, QD | 2 0.02 88.16 300 MG/D | 2 0.02 88.18 300 MG/DAY | 3 0.03 88.21 300 MG/THREE TIMES PER DAY/ORAL | 1 0.01 88.22 300 MGG ORAL | 1 0.01 88.23 300-400 MG, DAILY TAPER, ORAL | 1 0.01 88.24 300-400MG QD ORAL | 1 0.01 88.25 3000MG PER DAY | 2 0.02 88.27 300MG AT NIGHT | 1 0.01 88.28 300MG PER DAY | 7 0.07 88.35 30IU PER DAY | 1 0.01 88.36 30MG PER DAY | 4 0.04 88.40 30MG THREE TIMES PER DAY | 2 0.02 88.42 30MG TWICE PER DAY | 1 0.01 88.43 30MG VARIABLE DOSE | 1 0.01 88.44 30MG, 3 X PER WEEK, INTRAVENOUS | 1 0.01 88.45 30MG/DAY | 1 0.01 88.46 32 MG QD PO | 1 0.01 88.47 320 MG ONCE IV | 1 0.01 88.48 320 MG, QD | 1 0.01 88.49 325 MG | 1 0.01 88.50 325 MG DAY ONE INTRAVENOUS | 1 0.01 88.51 325 MG, BID | 1 0.01 88.52 325MG PER DAY | 1 0.01 88.53 33 MG | 1 0.01 88.54 334 MG ONCE INTRAVENOUS | 1 0.01 88.55 35 MG, 1/WEEK, ORAL | 1 0.01 88.56 35 MG, DAILY X 29 DAYS | 1 0.01 88.57 35MG WEEKLY | 1 0.01 88.58 360 MG | 1 0.01 88.59 360 MG PER _CYCLE IV | 1 0.01 88.60 360 MG SQ DAILY | 1 0.01 88.61 37.5 DF DAILY | 1 0.01 88.62 37.5 MG 2X PER 1 DAY ORAL | 1 0.01 88.63 37.5 MG/DAY | 1 0.01 88.64 38 U DAY | 1 0.01 88.65 3G PER DAY | 3 0.03 88.68 3MG PER DAY | 1 0.01 88.69 3ML PER DAY | 1 0.01 88.70 3TAB PER DAY | 4 0.04 88.74 3U PER DAY | 1 0.01 88.75 3UD PER DAY | 1 0.01 88.76 3UNIT PER DAY | 1 0.01 88.77 3UNIT TWICE PER DAY | 1 0.01 88.78 4 CAPSULE, 2 IN 1 DAY, PER ORAL | 1 0.01 88.79 4 G/DAY | 1 0.01 88.80 4 IN 1 D, PER ORAL | 1 0.01 88.81 4 IN 24 HOUR, ORAL | 1 0.01 88.82 4 MG (4 MG, 1 IN 1 D)ORAL | 1 0.01 88.83 4 MG 1 X PER 1 DAY, ORAL | 1 0.01 88.84 4 MG EVERY 4 WEEKS | 2 0.02 88.86 4 MG MONTHLY | 1 0.01 88.87 4 MG MONTHLY (ONE TIME DOSE) | 1 0.01 88.88 4 MG Q2H PRN INTRAVENOUS | 1 0.01 88.89 4 MG QD ORAL | 1 0.01 88.90 4 MG TWICE DAIL ORAL | 1 0.01 88.91 4 MG, DAILY X 6 MONTHS, ORAL | 1 0.01 88.92 4 MG, ONCE/SINGLE | 4 0.04 88.96 4 MG, QMO | 4 0.04 89.00 4 MG/D | 2 0.02 89.02 4 MG/DAY | 2 0.02 89.04 4 MIU, EVERY 2D, SUBCUTANEOUS | 2 0.02 89.06 4 UNITS AM, 5 UNITS PM | 1 0.01 89.07 4-10 OER SUBLINGUAL | 1 0.01 89.08 4.5 MG | 1 0.01 89.09 4.5MG PER DAY | 1 0.01 89.10 4.6MG PER DAY | 2 0.02 89.12 40 MG | 2 0.02 89.14 40 MG (10 MG), PO | 1 0.01 89.15 40 MG 1X PER 1 DAY ORAL | 1 0.01 89.16 40 MG 2X PER 1 DAY | 1 0.01 89.17 40 MG BID ORAL | 1 0.01 89.18 40 MG DAILY | 1 0.01 89.19 40 MG DAILY IV | 1 0.01 89.20 40 MG DAILY PO | 5 0.05 89.25 40 MG DAILY; SQ | 1 0.01 89.26 40 MG DAY | 3 0.03 89.29 40 MG PO | 7 0.07 89.36 40 MG PO BID | 1 0.01 89.37 40 MG QD PO | 3 0.03 89.40 40 MG QD X 4DAYS/MONTH | 1 0.01 89.41 40 MG, 1 IN 2 WK, SUBCUTANEOUS | 5 0.05 89.46 40 MG, BID | 1 0.01 89.47 40 MG, DAILY X 6 MONTHS, ORAL | 1 0.01 89.48 40 MG, DAYS 1-4, ORAL | 1 0.01 89.49 40 MG, ORAL | 1 0.01 89.50 40 MG, QD | 2 0.02 89.52 40 MG, QD FOR 4 DAYS EVERY MONTH | 1 0.01 89.53 40 MG, QD, ORAL | 1 0.01 89.54 40 MG, SUBCUTANEOUS | 1 0.01 89.55 40 MG, UNK | 1 0.01 89.56 40 MG/D | 4 0.04 89.60 40 MG/DAY | 3 0.03 89.63 40 MG/M2 EVERY 4 WEEKS | 1 0.01 89.64 40 UNITS AM, 30 UNITS PM SQ | 1 0.01 89.65 40,000 MG (40MG, 1 IN 1D) | 1 0.01 89.66 400 MG BID ORAL | 1 0.01 89.67 400 MG DAILY | 1 0.01 89.68 400 MG DAILY ORAL | 1 0.01 89.69 400 MG INTRAVENOUS (NOS) | 1 0.01 89.70 400 MG IV X 1 | 1 0.01 89.71 400 MG PER_CYCLE IV | 1 0.01 89.72 400 MG PO | 1 0.01 89.73 400 MG PO BID | 1 0.01 89.74 400 MG PO BID PRN | 1 0.01 89.75 400 MG PO Q DAY FOR 10 DAYS THERAPY | 1 0.01 89.76 400 MG PO X2 DOSES | 1 0.01 89.77 400 MG Q 12 H ORAL | 1 0.01 89.78 400 MG QD PO | 1 0.01 89.79 400 MG THREE TIMES DAILY, ORAL | 1 0.01 89.80 400 MG, BID | 2 0.02 89.82 400 MG, DAILY | 1 0.01 89.83 400 MG, DAILY, ORAL | 1 0.01 89.84 400 MG, INTRAVENOUS | 2 0.02 89.86 400 MG, IU | 1 0.01 89.87 400 MG, ONCE/SINGLE | 1 0.01 89.88 400 MG, ORAL | 1 0.01 89.89 400 MG, PER ORAL | 1 0.01 89.90 400 MG, QD | 3 0.03 89.93 400 MG, QD, ORAL | 1 0.01 89.94 400 MG/D | 3 0.03 89.97 400 MG/M2 | 1 0.01 89.98 400-500 IU, QD | 1 0.01 89.99 400-950 MG QD ORAL | 1 0.01 90.00 4000 MG + 10 MG QHS SQ X 5 NIGHTLY /WK | 1 0.01 90.01 400MG PER DAY | 3 0.03 90.04 400MG QHS ORAL | 1 0.01 90.05 400MG THREE TIMES PER DAY | 1 0.01 90.06 400MG/M2 DAYS 1,8,2 INTRAVENOUS | 1 0.01 90.07 400ML PER DAY | 1 0.01 90.08 40IU PER DAY | 1 0.01 90.09 40MG IN THE MORNING | 1 0.01 90.10 40MG PER DAY | 16 0.16 90.26 40MG TWICE PER DAY | 2 0.02 90.28 40MG/DAY | 1 0.01 90.29 423 MG IV | 1 0.01 90.30 44 U/1 DAY | 1 0.01 90.31 45 MG PO QD | 1 0.01 90.32 45 MG/M2 IV DAYS 1,3 | 1 0.01 90.33 450 MG, QHS | 1 0.01 90.34 4500MG PER DAY | 1 0.01 90.35 47.5 MG, QD, ORAL | 1 0.01 90.36 47.5 MG/DAY | 1 0.01 90.37 472 MG(TOTAL DOSE OVER 4 CYCLES ) | 1 0.01 90.38 4720 MG (TOTAL DOSE OVER 4 CYCLES) | 1 0.01 90.39 4G PER DAY | 1 0.01 90.40 4MCG/HR, ED | 1 0.01 90.41 4MG PER DAY | 10 0.10 90.51 4UNIT PER DAY | 1 0.01 90.52 5 MG (1 IN 1 D), ORAL | 2 0.02 90.54 5 MG (5 MG, 1 IN 1 D), ORAL | 1 0.01 90.55 5 MG 1 IN 1 D, ORAL 10 YEARS AGO | 1 0.01 90.56 5 MG BID PO | 1 0.01 90.57 5 MG DAILY IV | 1 0.01 90.58 5 MG DAILY PO | 5 0.05 90.63 5 MG IM | 1 0.01 90.64 5 MG MON. WED AND FRI | 1 0.01 90.65 5 MG PO | 19 0.19 90.84 5 MG PO HS | 1 0.01 90.85 5 MG PO TID | 1 0.01 90.86 5 MG QD PO | 12 0.12 90.98 5 MG QD; PO | 1 0.01 90.99 5 MG QOD PO | 1 0.01 91.00 5 MG TID PO | 2 0.02 91.02 5 MG, IN 1 DAY,ORAL | 1 0.01 91.03 5 MG, ORAL | 1 0.01 91.04 5 MG, QD | 2 0.02 91.06 5 MG, QD,ORAL | 1 0.01 91.07 5 MG, UNK | 2 0.02 91.09 5 MG/2 DAY | 1 0.01 91.10 5 MG/DAY | 1 0.01 91.11 5 MG/KG, 4 IN , INTRAVENOUS | 1 0.01 91.12 5 MG/KG, INTRAVENOUS | 1 0.01 91.13 5 QD | 2 0.02 91.15 5 US UNITS PPD-S ID | 1 0.01 91.16 5-10 ML 4-6 HOURS ORAL | 1 0.01 91.17 5-10 MG EVERY 4 HOURS PRN | 1 0.01 91.18 5/500 MG TID | 1 0.01 91.19 50 MG PO | 1 0.01 91.20 50 MG (50 MG, 1 IN 1 D), ORAL | 1 0.01 91.21 50 MG (50 MG, AS NEEDED), ORAL | 1 0.01 91.22 50 MG 3X PER 1 DAY | 1 0.01 91.23 50 MG 4X PER 1 DAY ORAL | 1 0.01 91.24 50 MG AS NEEDED, ORAL | 1 0.01 91.25 50 MG DAILY PO, DAILY PO | 1 0.01 91.26 50 MG IV | 1 0.01 91.27 50 MG ONCE PO | 1 0.01 91.28 50 MG PO | 1 0.01 91.29 50 MG QD | 1 0.01 91.30 50 MG QD PO | 1 0.01 91.31 50 MG QD, PO | 1 0.01 91.32 50 MG, 1 IN 1 D, INTRAVENOUS | 1 0.01 91.33 50 MG, BID | 2 0.02 91.35 50 MG, DAILY, ORAL | 2 0.02 91.37 50 MG, INTRAVENOUS | 1 0.01 91.38 50 MG, PRN | 1 0.01 91.39 50 MG, QD | 2 0.02 91.41 50 MG/D | 3 0.03 91.44 50 MG/DAY | 5 0.05 91.49 50 MIU QWK INTRAVESICAL | 1 0.01 91.50 50 U/1 IN THE MORNING | 1 0.01 91.51 50 UG/HR, 1 IN 72 HOUR, TRANSDERMAL | 4 0.04 91.55 50 UG/HR, TRANSDERMAL | 2 0.02 91.57 500 MCG/Q 5 DAYS S/C | 1 0.01 91.58 500 MG 1 TAB PO@ ORAL | 1 0.01 91.59 500 MG BID | 1 0.01 91.60 500 MG DAILY PO | 1 0.01 91.61 500 MG PO BID | 1 0.01 91.62 500 MG PO BID [3 DOSES ONLY] | 1 0.01 91.63 500 MG TID PO | 1 0.01 91.64 500 MG, 1 IN 1 DAY, ORAL | 1 0.01 91.65 500 MG, 2 IN 1 D, PER ORAL | 2 0.02 91.67 500 MG, BID | 2 0.02 91.69 500 MG, INTRAVENOUS | 1 0.01 91.70 500 MG, QD | 2 0.02 91.72 500 MG, SUBCUTANEOUS | 1 0.01 91.73 500 MG, UNK | 1 0.01 91.74 500 MG/DAY | 2 0.02 91.76 500 UNK (250 UNK, 2 IN 1 D), ORAL | 1 0.01 91.77 5000 U SC BID | 1 0.01 91.78 5000 U SQ BID | 1 0.01 91.79 500MG QHS W/ LOW ORAL | 1 0.01 91.80 500MG 3X/1 D AY; 1G / DAY | 1 0.01 91.81 500MG PER DAY | 3 0.03 91.84 500MG SIX TIMES PER DAY | 1 0.01 91.85 500MG TWICE PER DAY | 2 0.02 91.87 500MG, TID, PO | 1 0.01 91.88 500ML PER DAY | 2 0.02 91.90 50MCG TWICE PER DAY | 1 0.01 91.91 50MG PER DAY | 8 0.08 91.99 50MG THREE TIMES PER DAY | 1 0.01 92.00 50MG TWICE PER DAY | 1 0.01 92.01 50MG UNKNOWN | 3 0.03 92.04 50MG/DAY | 1 0.01 92.05 50MG/NOCTE | 1 0.01 92.06 510MG PER DAY | 1 0.01 92.07 52 MG QD INTRAVENOUS | 1 0.01 92.08 5220 MG Q2W INTRAVENOUS NOS | 1 0.01 92.09 5220 MG Q2W; INTRAVENOUS NOS | 1 0.01 92.10 53 MG ON DAY 1 OF PROTOCOL | 1 0.01 92.11 54 MG, 1 IN 1 DAY, ORAL | 1 0.01 92.12 550 MG BID; PO | 1 0.01 92.13 550 MG, INTRAVENOUS | 1 0.01 92.14 560 MG SQ X 8 HRS 5 NIGHTS/WK | 1 0.01 92.15 59MG IV | 1 0.01 92.16 5G PER DAY | 2 0.02 92.18 5MG PATCH | 1 0.01 92.19 5MG PER DAY | 10 0.10 92.29 5MG TEN TIMES PER DAY | 1 0.01 92.30 5MG THREE TIMES PER DAY | 1 0.01 92.31 5MG TWICE PER DAY | 1 0.01 92.32 5MGML PER DAY | 1 0.01 92.33 5ML FIVE TIMES PER DAY | 1 0.01 92.34 5UD PER DAY | 1 0.01 92.35 6 G, QD, ORAL | 1 0.01 92.36 6 G, UNK | 1 0.01 92.37 6 MG Q1HR | 1 0.01 92.38 6 MG, BID | 1 0.01 92.39 6 MG, IN 1 WEEK, ORAL | 1 0.01 92.40 6 MG, PRN | 1 0.01 92.41 6 MG/D | 1 0.01 92.42 6 MG/KG | 3 0.03 92.45 6 TAB/DAY | 1 0.01 92.46 60 MG | 3 0.03 92.49 60 MG DAY | 1 0.01 92.50 60 MG Q AM ORAL | 1 0.01 92.51 60 MG, QHS | 1 0.01 92.52 60 MG, TID | 1 0.01 92.53 60 MG/1 DAY | 5 0.05 92.58 60 MG/D | 2 0.02 92.60 60 MG/DAY | 1 0.01 92.61 60 MG/M2 IV EVERY 3WKS | 1 0.01 92.62 60 MG/M2 X 3, ONE DOSE /TOTAL DOSE 33.. | 1 0.01 92.63 60 MG/M^2 IV ONCE | 1 0.01 92.64 600 MG PO | 1 0.01 92.65 600 MG (200 MG, 3 IN 1D), ORAL | 1 0.01 92.66 600 MG BID | 2 0.02 92.68 600 MG BID ORAL | 1 0.01 92.69 600 MG ORAL | 1 0.01 92.70 600 MG Q 12 H INTRAVENOUS | 1 0.01 92.71 600 MG Q DAY PO | 1 0.01 92.72 600 MG TAKEN AM AND 400 MG TAKEN PM. | 1 0.01 92.73 600 MG, 1 IN 1 DAY, ORAL | 1 0.01 92.74 600 MG, BID, ORAL | 1 0.01 92.75 600 MG, DAILY | 1 0.01 92.76 600 MG, QD | 1 0.01 92.77 600 MG/D | 5 0.05 92.82 600 MG/DAY | 1 0.01 92.83 600MG PER DAY | 4 0.04 92.87 60MG IN THE MORNING | 1 0.01 92.88 60MG PER DAY | 7 0.07 92.95 62.5MCG PER DAY | 1 0.01 92.96 640 UG | 1 0.01 92.97 650-1300 MG TID PRN | 1 0.01 92.98 654 MG IV | 1 0.01 92.99 6540 MG | 1 0.01 93.00 6MG ALTERNATING WITH 7MG, QD,ORAL | 1 0.01 93.01 6MG PER DAY | 1 0.01 93.02 6MG/KG | 2 0.02 93.04 6UNIT PER DAY | 2 0.02 93.06 7 MG/KG, INTRAVENOUS | 1 0.01 93.07 7 U, TOTAL DAILY | 1 0.01 93.08 7.5 G, UNK | 1 0.01 93.09 7.5 MG (7.5 MG)PO' 1 DOSE | 1 0.01 93.10 7.5 MG (7.5 MG, 1 DAILY) | 1 0.01 93.11 7.5 MG (7.5 MG, 7,5 MG) PO | 1 0.01 93.12 7.5 MG Q 28 DAYS SQ | 1 0.01 93.13 7.5 MG, TOTAL DAILY, ORAL | 1 0.01 93.14 7.5MG 1 XER 1 DAY | 1 0.01 93.15 7.5MG PER DAY | 1 0.01 93.16 7.5MG/NOCTE | 1 0.01 93.17 70 MG DAY | 1 0.01 93.18 70 MG ON DAY 1 | 1 0.01 93.19 70 MG, SINGLE, INTRAVENOUS | 1 0.01 93.20 70 U DAY | 1 0.01 93.21 700 MG QD ORAL | 1 0.01 93.22 700 MG/M2 Q2W , INTRAVENOUS NOS | 1 0.01 93.23 700 MG/M2 Q2W INTRAVENOUS NOS | 1 0.01 93.24 70MG PER DAY | 1 0.01 93.25 72 IU, QD, SUBCUTANEOUS; 32 IU, QD, S.. | 1 0.01 93.26 74.8 MG, 1 IN 1 TOTAL, ORAL | 1 0.01 93.27 75 - 600 MG/DAY | 1 0.01 93.28 75 M OD ; ORAL | 1 0.01 93.29 75 MCG/HOUR | 1 0.01 93.30 75 MG | 1 0.01 93.31 75 MG (TID), ORAL | 1 0.01 93.32 75 MG 1 X PER 1 DAY, ORAL | 1 0.01 93.33 75 MG 2X PER 1 DAY, ORAL | 1 0.01 93.34 75 MG OD , ORAL | 1 0.01 93.35 75 MG OD ORAL | 1 0.01 93.36 75 MG OD, ORAL | 1 0.01 93.37 75 MG QDAY ORAL | 1 0.01 93.38 75 MG, 1 IN 1 D, PER ORAL | 1 0.01 93.39 75 MG, BID | 1 0.01 93.40 75 MG, DAILY | 1 0.01 93.41 75 MG, QD | 1 0.01 93.42 75 MG, UNK | 1 0.01 93.43 75 MG/DAY | 1 0.01 93.44 75 MG/M2 Q 3 WK | 1 0.01 93.45 75 UG. 1 IN 72 HOUR, TRANSDERMAL | 1 0.01 93.46 75 UG/DAY | 1 0.01 93.47 75 UG/HR, 1 IN 72 HOUR, TRANSDERMAL | 6 0.06 93.53 75 UG/HR, 1 IN 72 HOUR, TRANSDERMAL; .. | 1 0.01 93.54 75 UG/HR, TRANSDERMAL | 1 0.01 93.55 75 UG/KG, 1 IN 72 HOUR, TRANSDERMAL | 1 0.01 93.56 75,000 (75 MG, 1 IN 1 D) | 1 0.01 93.57 750 MG DAILY PO | 1 0.01 93.58 750 MG Q 8 IV | 1 0.01 93.59 750 MG SQ DAILY | 1 0.01 93.60 750 Q 21DAYS INTRAVENOUS | 1 0.01 93.61 75G PER DAY | 1 0.01 93.62 75MCG PER DAY | 1 0.01 93.63 75MG PER DAY | 7 0.07 93.70 75MG/DAY | 1 0.01 93.71 75MGM2 SINGLE DOSE | 1 0.01 93.72 77 MG DAY 1 INTRAVENOUS | 1 0.01 93.73 77MG DAY 1 INTRAVENOUS | 1 0.01 93.74 8 MG ( 8 MG, 1 IN 1 D), ORAL | 1 0.01 93.75 8 MG PO QD | 1 0.01 93.76 8 MG, 2 IN 1 DAY, ORAL | 1 0.01 93.77 8 MG/KG, SINGLE, INTRAVENOUS | 1 0.01 93.78 8 MIU, EVERY 2D, SUBCUTANEOUS | 4 0.04 93.82 8 U DAY | 1 0.01 93.83 8 U/1 DAY | 1 0.01 93.84 8 VIALS INTRAVENOUS | 1 0.01 93.85 80 IU DAILY; SQ | 1 0.01 93.86 80 MG | 2 0.02 93.88 80 MG (80 MG, 1 IN 1 D) | 1 0.01 93.89 80 MG BID/SHORT DURATION | 1 0.01 93.90 80 MG DAILY PO | 3 0.03 93.93 80 MG DAY | 3 0.03 93.96 80 MG IV Q WK | 1 0.01 93.97 80 MG NA | 1 0.01 93.98 80 MG ONCE IV | 1 0.01 93.99 80 MG ONE DAILY ORAL | 1 0.01 94.00 80 MG PO BID | 2 0.02 94.02 80 MG, 1 TAB OD, PO | 1 0.01 94.03 80 MG, BID | 1 0.01 94.04 80 MG, QD | 4 0.04 94.08 80 MG, UNK | 2 0.02 94.10 80 MG/ M2 Q WK | 1 0.01 94.11 80 MG/1 DAY | 2 0.02 94.13 80 MG/DAY | 3 0.03 94.16 80 MG/DF INTRAMUSCULAR/ORAL | 1 0.01 94.17 80 MG/M2 CONT- INTRAVENOUS NOS | 1 0.01 94.18 80-30MG DAILY, PO | 1 0.01 94.19 800 MG , ORAL | 1 0.01 94.20 800 MG 1X PER 8 WK, INTRAVENOUS | 2 0.02 94.22 800 MG DAY I IV | 1 0.01 94.23 800 MG TID PO | 1 0.01 94.24 800 MG, DAILY | 1 0.01 94.25 800 MG/D | 1 0.01 94.26 800 MG/M2 OTHER | 1 0.01 94.27 800 MG/M2 OTHR | 1 0.01 94.28 80000 UNITS | 1 0.01 94.29 800MG PER DAY | 1 0.01 94.30 80MG PER DAY | 3 0.03 94.33 81 MG PO QD | 1 0.01 94.34 81 MG QWK INTRAVESICAL | 1 0.01 94.35 81MG PER DAY | 2 0.02 94.37 85 MG/M2 Q2W, INTRAVENOUS NOS | 1 0.01 94.38 85 MG/M2 Q2W, INTRAVENOUS | 1 0.01 94.39 850 MG X2 | 1 0.01 94.40 850MG PER DAY | 1 0.01 94.41 850MG THREE TIMES PER DAY | 1 0.01 94.42 850MG TWICE PER DAY | 1 0.01 94.43 8MG IN THE MORNING | 1 0.01 94.44 8MG PER DAY | 6 0.06 94.50 8MG TWICE PER DAY | 1 0.01 94.51 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS | 1 0.01 94.52 9 MG/M^2 DAY 1, INTRAVENOUS; 9 MG/M^.. | 1 0.01 94.53 9 U DAY | 1 0.01 94.54 9.375MG TWICE PER DAY | 1 0.01 94.55 90 MG DAILY PO, 90 MG DAILY PO | 1 0.01 94.56 90 MG EVERY 12 H SUBCUTANEOUS | 1 0.01 94.57 90 MG/DAY | 1 0.01 94.58 900 MG (300 MG, 3 IN 1 D), ORAL | 1 0.01 94.59 900 MG HS PO | 1 0.01 94.60 900 MG, INTRAVENOUS | 1 0.01 94.61 900 TWICE/WEEK PO [4 DOSES] | 1 0.01 94.62 900MG PER DAY | 2 0.02 94.64 94 MG IV | 1 0.01 94.65 948 MG (DAY 1 Q 21DAYS), INTRAVENOUS | 1 0.01 94.66 96 MCG QWK SUBCUTANEOUS | 1 0.01 94.67 960 MCG | 1 0.01 94.68 990 MG (330 MG, 3 IN 1 D), ORAL | 1 0.01 94.69 990MG PER DAY | 1 0.01 94.70 ACTUAL DOSE 2000 MG. FOR TWO WEEKS DO.. | 1 0.01 94.71 ACTUAL DOSE: 249.6 MG | 1 0.01 94.72 ADMINISTERED AS ^ALLERGY PROPHYLAXIS^ | 3 0.03 94.75 ADMINISTERED AS ^PROPHYLAXIS FOR CHOL.. | 3 0.03 94.78 ADMINISTERED AS ^VOMITING PROPHYLAXIS^ | 3 0.03 94.81 ALBUMIN INFUSION. STOPPED ON 5 MAY A.. | 1 0.01 94.82 ALTERED DUE TO ADVERSE EVENT/TOXICITY. | 2 0.02 94.84 AS REQUIRED | 1 0.01 94.85 AT HOUR OF SLEEP | 2 0.02 94.87 AT NOON | 1 0.01 94.88 AUC 6; CYCLE 1: FEB-2004 | 1 0.01 94.89 AUC 6; CYCLE 1: OCT-2003 | 1 0.01 94.90 BACK TO PROTOCOL TAPER. | 2 0.02 94.92 CARD | 1 0.01 94.93 CHANGE IN STRENGTH : 135 MCG / UNKNOWN. | 1 0.01 94.94 CODE NOT BROKEN | 2 0.02 94.96 COMMERCIAL MMF. | 1 0.01 94.97 CUTANEOUS | 16 0.16 95.13 CUTANOUS | 2 0.02 95.15 CYCLE 1: FEB-2004 | 1 0.01 95.16 CYCLE 1: JUL-1999 | 1 0.01 95.17 CYCLE 1: JUL-1999; AUC 7.5 | 1 0.01 95.18 CYCLE 1: OCT-2003 | 1 0.01 95.19 CYCLE 2, IV | 2 0.02 95.21 CYCLE 2, ORAL | 1 0.01 95.22 DAILY | 2 0.02 95.24 DAY 3 INTRAVENOUS | 1 0.01 95.25 DECREASED DUE TO ADVERSE EVENT/TOXICI.. | 2 0.02 95.27 DF INTRAVENOUS (NOS) | 1 0.01 95.28 DOSAGE FORM - PUFF | 1 0.01 95.29 DOSAGE FORM = 1 CAPSULE | 1 0.01 95.30 DOSAGE FORM = BAGS | 1 0.01 95.31 DOSAGE REGIMEN REPORTED AS 3.6G/2 X 2.. | 1 0.01 95.32 DOSAGE REGIMEN WAS REPORTED AS 10 MG. | 1 0.01 95.33 DOSAGE: 2ML X 10 MG/ML | 2 0.02 95.35 DOSAGE: 2ML X 10MG/ML | 2 0.02 95.37 DOSE UNIT: UNITS | 5 0.05 95.42 DOSE VALUE: 3 UNIT; DURATION OF THE.. | 1 0.01 95.43 DOSE: 15 MG WEEKLY | 1 0.01 95.44 DOSE: 3 TABLETS | 1 0.01 95.45 DOSE: 4 CYCLES | 2 0.02 95.47 DOSE: 500-0-500 | 1 0.01 95.48 DOSE: 6 CAPSULE | 1 0.01 95.49 DOSE: 60/120 | 1 0.01 95.50 DOSE: 70 MG WEEKLY | 1 0.01 95.51 DOSE: 8 PUFFS | 1 0.01 95.52 DOSE: 8 UNITS | 1 0.01 95.53 DOSE: AUC=1.5 | 1 0.01 95.54 DOSE: MOUTHWASH | 4 0.04 95.58 DOSE: NOT PROVIDED | 9 0.09 95.67 DOSE: UNK | 45 0.45 96.12 DOSE: UNKNOWN | 3 0.03 96.15 DOSE:6-8 MG/DAY FOR 8-10 DAYS/MO | 1 0.01 96.16 DOSING FOR 3 WKS, W/ 1 WK OFF | 1 0.01 96.17 DRIP X 7 DAYS | 1 0.01 96.18 DRUG NAME - SENE, NOT FOUND ON ADVENT. | 1 0.01 96.19 DRUG NAME REPORTED AS ADACOLUMN. | 1 0.01 96.20 DRUG NAME REPORTED AS LASILIX LP. | 1 0.01 96.21 DRUG NAME: ARANDEN | 1 0.01 96.22 DRUG NAME: ERY. | 1 0.01 96.23 DRUG REPORTED AS BIO-PUNCH | 1 0.01 96.24 DRUG REPORTED AS LIPOSTATINS. | 1 0.01 96.25 DURATION OF THERAPY: ^FEW YEARS^ | 2 0.02 96.27 DURATION OF TREATMENT: 6-7 WEEKS | 1 0.01 96.28 DURATION: SEVERAL YEARS | 1 0.01 96.29 FOETAL DRUG EXPOSURE VIA FATHER | 2 0.02 96.31 FOR FOUR DOSES. | 1 0.01 96.32 FORM WAS REPORTED AS INJECTABLE SOLUT.. | 1 0.01 96.33 FORM: REPORTED AS DRY SYRUP. | 2 0.02 96.35 FORMULATION = PILLS. | 1 0.01 96.36 FREQUENCY: AFTER MEALS | 2 0.02 96.38 FREQUENCY: BEFORE MEALS AND AT BEDTIME | 1 0.01 96.39 GARGLE | 1 0.01 96.40 GEL 1% | 2 0.02 96.42 GIVEN AT NIGHT. | 1 0.01 96.43 GIVEN FOR ONE DAY ON 13 MAY AND RESTA.. | 1 0.01 96.44 GIVEN FROM DAYS ONE TO FOURTEEN OF A .. | 1 0.01 96.45 GIVEN ON DAYS ONE AND EIGHT OF A THRE.. | 1 0.01 96.46 HELD FOR 7 DAYS | 3 0.03 96.49 IN AM AND HOUR OF SLEEP | 1 0.01 96.50 IN LOWER DOSAGE FOR 7 MONTHS | 1 0.01 96.51 INCREASED TO 40 MG UNTIL 26-JAN, + TH.. | 1 0.01 96.52 INHALATION | 1 0.01 96.53 INITIAL DOSE ON 14-DEC-2002 | 1 0.01 96.54 INITIAL DOSE-2 TABLETS THREE TIMES DA.. | 1 0.01 96.55 INITIAL INFUSION. TREATMENT WAS DELAY.. | 3 0.03 96.58 INITIAL TX DATE: 04-MAY-04. PT HAD R.. | 1 0.01 96.59 INITIAL TX DATE: 04-MAY-04. 7 DOSES A.. | 1 0.01 96.60 INITIAL TX DATE: 04-MAY-04. PT HAD RE.. | 1 0.01 96.61 INITIATED 13-APR-2004 | 2 0.02 96.63 INITIATED AT 10 MG ON 12/9/2003, 20 M.. | 1 0.01 96.64 INITIATED AT 50 MG DAILY, INCREASED T.. | 1 0.01 96.65 INITIATED AT 60 MG, INCREASED TO 80 M.. | 1 0.01 96.66 INJECTABLE | 6 0.06 96.72 INJECTION | 4 0.04 96.76 INTRAMUSCULAR | 1 0.01 96.77 INTRAVENOUIS | 1 0.01 96.78 INTRAVENOUS | 10 0.10 96.88 INTRAVENOUS (NOS) | 1 0.01 96.89 INVESTIGATOR CLARIFIED THE PATIENT WA.. | 1 0.01 96.90 IU | 1 0.01 96.91 IV | 8 0.08 96.99 IV FLUSHES, T | 1 0.01 97.00 IV, ONCE | 1 0.01 97.01 IVPB Q 8 HR | 1 0.01 97.02 LINEAC 50 GY, RALS 30 GY TO THE PELVI.. | 1 0.01 97.03 LOADING DOSE: 6MG/DAY PO MAINTENANCE .. | 1 0.01 97.04 MG, PO | 1 0.01 97.05 MOST RECENT INFUSION ON 17-JUN-04. PT.. | 1 0.01 97.06 MOST RECENT INFUSION:10-JUN-04. PT HA.. | 1 0.01 97.07 NI | 14 0.14 97.21 NI; IV | 1 0.01 97.22 ON DURING THE DAY AND OFF AT NIGHT | 1 0.01 97.23 ON HOLD ORAL | 1 0.01 97.24 ONCE PER DAY ORAL | 1 0.01 97.25 ONE DAILY ORAL | 1 0.01 97.26 ONE DOSE PO TID X 10 DAYS | 1 0.01 97.27 ONE DOSE TWICE DAIL ORAL | 1 0.01 97.28 ONE MOUTH PILL-D | 1 0.01 97.29 ONE PUFF ONE PUFF P | 1 0.01 97.30 ONE TIME SPRAY | 1 0.01 97.31 ONE, 0.5 ML | 1 0.01 97.32 ORAL | 50 0.50 97.82 ORAL - ONCE EVERY 24 HRS X 3 DAYS | 1 0.01 97.83 ORAL/IV | 1 0.01 97.84 PARENTERAL | 1 0.01 97.85 PER ORAL | 7 0.07 97.92 PO | 8 0.08 98.00 POWDER FOR RECONSTITUTION, 500 MG | 2 0.02 98.02 PRN, ORAL | 1 0.01 98.03 PT. REC'D 14 COURSES | 3 0.03 98.06 Q 72 HOURS | 1 0.01 98.07 Q WEEK | 1 0.01 98.08 QD | 3 0.03 98.11 QD PRN | 1 0.01 98.12 QID PRN | 1 0.01 98.13 REC'D 5 INFUSIONS | 2 0.02 98.15 RECENTLY INCREASED TO 80 MG/DAY | 1 0.01 98.16 REDUCED FROM 10 MG (17NOV03 - 16JAN04) | 1 0.01 98.17 REDUCED TO 400 MG ONCE PER DAY 15-DEC.. | 1 0.01 98.18 REPORTED AS BECLOMETASONE NASAL SPRAY | 1 0.01 98.19 REPORTED AS: PRN. | 1 0.01 98.20 RESTARTED STUDY MYCOPHENOLATE MOFETIL.. | 1 0.01 98.21 RIBAVIRIN DOSAGE WAS REDUCED TO 400 M.. | 1 0.01 98.22 ROUTE OF ADMINISTRATION REPORTED AS I.. | 1 0.01 98.23 SECOND DAY OF THERAPY 28-APR-2004 | 1 0.01 98.24 SEE IMAGE | 48 0.48 98.72 SEE IMAGE, ORAL | 2 0.02 98.74 SEE IMAGE; SINGLE DOSE | 1 0.01 98.75 SEE IMAGE; UPT TO 6 MONTHS; AFTER FIR.. | 1 0.01 98.76 SEE TEXT (NR) IU | 1 0.01 98.77 SEE TEXT (NR), IU | 8 0.08 98.85 SEE TEXT (SEE TEXT, 2 MG/KG, THEN 1 M.. | 1 0.01 98.86 SPRAY, INTRAAURICULAR, A FEW DAYS | 1 0.01 98.87 SQ Q12H | 1 0.01 98.88 STARTED BEFORE THERAPY WITH PEG INTER.. | 2 0.02 98.90 STOPPED ON 13 MAY AND RESTARTED ON 27.. | 1 0.01 98.91 STOPPED ON 2 MAY 2004 AND RESTARTED O.. | 1 0.01 98.92 STOPPED ON 2 MAY AND RESTARTED ON 17 .. | 1 0.01 98.93 STOPPED ON 22 MAY AND RESTARTED ON 27.. | 1 0.01 98.94 STOPPED ON 7 MAY AND RESTARTED ON 14 .. | 1 0.01 98.95 STRENGTH REPORTED AS 40,000 UNITS. | 1 0.01 98.96 SUB - Q | 1 0.01 98.97 SUBCUTANEOUS | 6 0.06 99.03 SUSPENSION | 2 0.02 99.05 TABELT, 10 MG | 1 0.01 99.06 TABLET | 1 0.01 99.07 TABLET 150 MG | 2 0.02 99.09 TABLET 325 MG | 1 0.01 99.10 TABLET 600 MG | 1 0.01 99.11 TABLET 800 MG | 1 0.01 99.12 TABLET 800 MG/160 MG | 1 0.01 99.13 TABLET ORALLY DISINTEGRATING | 1 0.01 99.14 TABLET, 10 MG | 1 0.01 99.15 TABLET, 5/500 | 1 0.01 99.16 TABLET, CHEWABLE 5 MG | 2 0.02 99.18 TABLETCOATEDPARTICLES 325 MG | 1 0.01 99.19 TAKEN AS A DIVIDED DAILY DOSE. | 1 0.01 99.20 TAKEN AS DIRECTED. | 1 0.01 99.21 TAKEN DAILY | 1 0.01 99.22 TAKEN EVERY DAY | 3 0.03 99.25 TEMPORARILY HELD ON 27-MAY-2004 | 1 0.01 99.26 TEMPORARILY HELD ON 27-MAY-2004, PERM.. | 1 0.01 99.27 TEMPORARILY HELD ON 27-MAY-2004, SWIT.. | 1 0.01 99.28 THE DOSE OF COPEGUS WAS REDUCED DUE T.. | 1 0.01 99.29 THERAPY DATES: 02-JAN-2004 TO 13-FEB-.. | 1 0.01 99.30 THERAPY DATES: 02-JAN-2004 TO 13-FEB2.. | 1 0.01 99.31 THERAPY DATES: 03 TO 17-JUN-2004 | 1 0.01 99.32 THERAPY DATES: 10-MAR-2004 TO 21-APR-.. | 1 0.01 99.33 THERAPY DATES: 10-MAR-2004 TO 21-APR-.. | 1 0.01 99.34 THERAPY DATES: 22 TO 29-MAY-2002 | 1 0.01 99.35 THERAPY INITATED FEB-2004. | 1 0.01 99.36 THERAPY INITIATED 20-APR-2004-PT RECE.. | 1 0.01 99.37 THERAPY INITIATED 20-APR-2004. PT REC.. | 1 0.01 99.38 THERAPY INITIATED FEB-2004. | 3 0.03 99.41 THERAPY INITIATED FEB-2004; DAYS 1 TO 5 | 1 0.01 99.42 TID PO/ APPROXIMATELY 1 1/2 MONTHS | 1 0.01 99.43 TOTAL DAILY DOSE ALSO REPORTED AS 2. | 2 0.02 99.45 TOTAL DAILY DOSE REPORTED AS 2. | 1 0.01 99.46 TRANSDERMAL | 9 0.09 99.55 TREATMENT FOR REJECTION. | 3 0.03 99.58 TWO CAP/TAB 4 X DAILY BY MOUTH | 1 0.01 99.59 TWO TABLETS, 320/25 MG, DAILY | 1 0.01 99.60 UNK | 3 0.03 99.63 UNK, BID | 2 0.02 99.65 UNK, NO TREATMENT | 1 0.01 99.66 UNK, ONCE/SINGLE | 1 0.01 99.67 UNK, PRN | 3 0.03 99.70 UNK, QD | 2 0.02 99.72 UNK, QMO | 1 0.01 99.73 UNK, UNK | 5 0.05 99.78 UNK, UNK, INTRA-UTERINE | 1 0.01 99.79 UNK,UNK | 1 0.01 99.80 UNK/UNK | 2 0.02 99.82 UNKNOWN | 5 0.05 99.87 UNKNOWN, ORAL | 1 0.01 99.88 UNSPECIFIED | 1 0.01 99.89 UP TO 32 MG/KG/DAY | 1 0.01 99.90 WARFARIN SODIUM INTERRUPTED AND RESTA.. | 1 0.01 99.91 ^0.62^ MG , ORAL | 1 0.01 99.92 ^125^ MG TWICE DAILY | 1 0.01 99.93 ^300 X 3^ | 1 0.01 99.94 ^40^ | 1 0.01 99.95 ^480 MG^ | 1 0.01 99.96 ^75^ | 1 0.01 99.97 ^TRYING TO WEAN OFF-CAN'T GET PAST TH.. | 1 0.01 99.98 ^UNKNOWN, 1 IN 1 WEEK^ | 1 0.01 99.99 `10 MG PO | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015